Finseta Reports 16% Revenue Growth in H1 2025 Despite Strategic Investments Impacting EBITDA
Finseta posts 16% H1 revenue growth as strategic investments in UAE, Canada & new products temporarily soften profits. Read the full analysis.
This article covers information on Finseta PLC.
LON:FINFinseta H1 2025: 16% revenue growth, EBITDA softer as strategy spend ramps
Finseta has posted a solid top line for the six months to 30 June 2025, with revenue up 16% to £5.9m. The business leaned into investment across product and geography – notably agency banking in the UK, a Dubai licence, a new Canadian office and the launch of a corporate card. That spend lowered profitability in the period, but management argues it sets up a faster, more diversified growth profile.
Macro did not help. FX volatility linked to tariff-related developments weighed on USD-related activity, delaying some client conversion. That drag is easing into H2, though less than previously expected, so full-year revenue growth is now guided to around 11%.
Key numbers at a glance
| Revenue | £5.9m (H1 2024: £5.1m) – up 16% |
| Gross margin | 62.7% (H1 2024: 65.7%) |
| Gross profit | £3.7m (H1 2024: £3.3m) |
| Adjusted EBITDA | £0.3m |
| Operating (loss)/profit | £(0.2)m (H1 2024: £0.6m profit) |
| (Loss)/profit before tax | £(0.26)m |
| Net (loss)/profit | £(0.21)m |
| Basic EPS | (0.37) pence |
| Cash and cash equivalents | £2.4m (31 Dec 2024: £2.6m) |
| Net cash | £0.4m |
| Cash generated from operations | £0.4m |
| Active customers | 1,101 (H1 2024: 952) |
| Revenue split | Corporate 58% | Private 42% (H1 2024: Corporate 38% | Private 60%) |
Note on EBITDA: the narrative in the financial review quotes H1 2024 adjusted EBITDA at £0.3m, while the statement of comprehensive income shows £0.8m. The table above follows the statement figure.
Operational progress that actually moves the needle
UAE licence already delivering
Finseta received DFSA approval under a Category 3D licence to provide payment services in the UAE. That unlocks local transactions – faster, cheaper and with a broader client set. Management says Dubai is growing ahead of expectations and plans to add sales capacity. Integration with local payment rails completes in the coming months, which should further improve speed and cost-to-serve.
Canada now live and contributing
The Canadian subsidiary is up and running following last year’s Money Services Business licence. It has started to generate revenue and built a pipeline. Local system integration is complete, which matters for service quality and margins.
Agency banking implemented post period
Agency banking means Finseta can now issue its own UK account numbers and is indirectly connected to Faster Payments. In plain English: easier onboarding for more customer types, and money moves quicker and more reliably. This takes Finseta a step closer to being a client’s primary payments provider rather than a niche FX add-on. The company frames this as stage one of broader network connectivity beyond the UK.
Corporate card launched – a new, repeatable revenue stream
The Finseta Corporate Card, powered by Mastercard, is available as virtual or physical cards with multi-currency functionality across 210+ countries. Early revenue has started, with more product improvements before a wider roll-out. Cards tend to carry high-margin, recurring interchange and fee income, so if adoption scales, mix should help earnings quality.
Customer dynamics: more corporates, slower HNWI activity
Active customers rose to 1,101, with a sizeable cohort onboarded but yet to transact. The latter is important: once USD-related headwinds ease, conversion could unlock incremental volume without extra acquisition cost.
Revenue mix shifted towards corporates – 58% versus 38% last year – as HNWIs pulled back in tougher macro conditions. Corporate clients can be stickier and more repeatable, so the direction of travel looks sensible even if HNWI volumes rebound later.
Margins, costs and cash: what’s under the bonnet
Gross margin dipped to 62.7% from 65.7%, reflecting revenue mix. Despite that, gross profit rose to £3.7m on higher volumes. Operating expenses increased to £3.9m from £2.8m as Finseta invested behind the UAE and Canada build-out, agency banking and card launch.
The bottom line was a small loss – £0.2m from operations and £0.21m after tax. Cash and cash equivalents ended at £2.4m, with £0.4m net cash after deducting loan notes. Operations generated £0.4m of cash, while investing outflows of £0.4m largely reflect spend on agency banking and software development (£313,746 of internally generated software, plus £62,781 of PPE).
There is a £2.0m loan note outstanding to a major shareholder and executive, carrying 6% interest and due on 31 July 2026. That is a medium-term liability rather than an immediate squeeze, but it is one to keep on the radar.
Guidance: revenue growth trimmed to c. 11% for FY 2025
USD-related activity is improving in H2 but “to a lesser extent than initially anticipated”. The Board now expects around 11% revenue growth for the full year. Cost discipline is emphasised, with total operating costs expected to be slightly lower than initially planned. Strategically, management continues to point to materially faster growth and improved profitability in the medium term as the UAE, Canada, agency banking and cards scale.
My take: why this update matters
There is a clear trade-off here. Finseta is accepting lower near-term EBITDA to build a broader, higher-quality platform. The UAE licence and agency banking are meaningful capability upgrades that can expand the customer universe and improve service levels. The corporate card adds a sticky, high-margin stream that should smooth revenue seasonality.
The negatives are straightforward: macro hit USD flows, HNWIs were quieter, and margins softened as mix shifted. Guidance has been nudged down and there is not a lot of balance sheet slack, so execution needs to stay tight. That said, cash generation from operations remained positive and the loan note maturity is in 2026.
What could go right in H2 and beyond
- Conversion of the larger pool of onboarded-but-inactive customers as FX conditions stabilise.
- UAE growth accelerates post integration with local payment systems, lowering costs and boosting speed.
- Corporate card adoption ramps, adding high-margin, repeatable income.
- Agency banking unlocks bigger or more complex UK clients, deepening wallet share.
What to watch for risks
- Prolonged USD volatility from policy or tariff headlines delaying client activity.
- Slower-than-planned roll-out of the corporate card or delays integrating new payment rails.
- Gross margin pressure from mix as the company scales new corridors and sectors.
- Liquidity headroom – cash stood at £2.4m – so disciplined cost control and working capital management remain important.
Jargon buster
- Adjusted EBITDA – a profit measure before interest, tax, depreciation and amortisation, adjusted for items the company views as non-core or non-cash.
- Agency banking – partnering with a bank to issue your own client account numbers and access payment schemes (such as Faster Payments) without being a bank yourself.
- HNWIs – high net worth individuals.
Housekeeping and next steps
There is a minor inconsistency in the RNS: the financial review text cites H1 2024 adjusted EBITDA at £0.3m, while the statement of comprehensive income shows £0.8m. The detailed statement figure appears to be the correct comparator given the line-by-line reconciliation.
Management will present at 9.30am BST today via Investor Meet Company. If you want to hear the Q&A straight from the team, you can register here: https://www.investormeetcompany.com/finseta-plc/register-investor
Bottom line
Finseta grew briskly, invested heavily and took a temporary hit to profits. The strategic pieces – UAE, Canada, agency banking and cards – are the right levers to broaden the moat and reduce reliance on FX-only revenues. With guidance reset to c. 11% revenue growth for 2025 and costs kept in check, delivery in H2 will hinge on converting the enlarged pipeline and sustaining momentum in Dubai and Canada. If those engines fire, the medium-term earnings mix should look stronger than it does today.
Related
Keep reading
Investing
AstraZeneca’s Enhertu delivers Phase III lung cancer PFS win
Enhertu delayed disease progression versus standard care in a Phase III lung cancer trial, supporting its potential move into first-line treatment.
JoshuaAugust 17, 2026
Investing
Optima Health FY26 results: growth beats expectations as PAM integration begins
Optima Health beat adjusted EBITDA expectations in FY26, while the £100 million PAM acquisition reshaped its growth prospects and balance sheet.
JoshuaAugust 17, 2026
Investing
Nostrum Oil & Gas Agrees $304.6 Million Kazakhstan Sale Ahead of Wind-Down
Nostrum plans to sell its Kazakhstan operations, repay secured notes in full and begin an orderly wind-down after completion.
JoshuaAugust 17, 2026
Last updated
Category
InvestingLikes
Star Rating
No ratings yet
Comments
No comments yet - start the conversation.